Pzena Investment Management LLC boosted its stake in Humana Inc. (NYSE:HUM – Free Report) by 34.3% in the first quarter, Holdings Channel.com reports. The fund owned 5,470,982 shares of the insurance provider’s stock after buying an additional 1,398,774 shares during the quarter. Humana comprises about 3.1% of Pzena Investment Management LLC’s portfolio, making the stock its 8th largest holding. Pzena Investment Management LLC’s holdings in Humana were worth $948,614,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. Montag A & Associates Inc. lifted its holdings in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the last quarter. CoreCap Advisors LLC increased its position in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new stake in Humana in the fourth quarter valued at approximately $27,000. Reflection Asset Management acquired a new stake in shares of Humana in the fourth quarter valued at approximately $29,000. Finally, Rosenberg Matthew Hamilton boosted its holdings in shares of Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages have recently commented on HUM. Mizuho lifted their target price on shares of Humana from $335.00 to $390.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Evercore raised their price objective on shares of Humana from $250.00 to $370.00 in a research report on Thursday, June 11th. TD Cowen upped their target price on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a report on Friday, May 1st. Robert W. Baird decreased their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Finally, Raymond James Financial reissued an “outperform” rating and set a $260.00 price target on shares of Humana in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $293.09.
Humana Stock Up 3.2%
HUM stock opened at $409.92 on Thursday. The stock has a market capitalization of $49.22 billion, a PE ratio of 43.84, a price-to-earnings-growth ratio of 2.26 and a beta of 0.71. The company has a fifty day moving average of $314.71 and a 200-day moving average of $248.64. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a one year low of $163.11 and a one year high of $414.82.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business’s revenue was up 23.5% compared to the same quarter last year. During the same period in the previous year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts expect that Humana Inc. will post 9.04 EPS for the current year.
Humana Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.
Humana Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
